Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.0005
-0.0001 (-16.67%)
At close: Nov 4, 2026
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $2.31 thousand as of November 11, 2026. It is the 52,324th most valuable company in the world and the 8,256th biggest in the United States. Its market cap has decreased by 99.89% in one year.
Market Cap
2.31K
Enterprise Value
-1.59M
Revenue
389.78K
Global Rank
Country Rank
#8,256 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 2.31K, a decrease of -99.99%. That is a compound annual growth rate of -91.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 2.31K | -99.72% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innoveren Scientific | 3.20K |
| Hemagen Diagnostics | 3.10K |
| Comera Life Sciences Holdings | 3.07K |
| Anthera Pharmaceuticals | 2.62K |
| OncoVista Innovative Therapies | 2.36K |
| Suvanza Pharma, LLC | 2.24K |
| Virpax Pharmaceuticals | 1.99K |
| Evelo Biosciences | 1.90K |